The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 8, Pages 2395
Publisher
MDPI AG
Online
2020-07-27
DOI
10.3390/jcm9082395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Endocannabinoid System: A Target for Cancer Treatment
- (2020) Chiara Laezza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
- (2020) Cifelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoids in the Pathophysiology of Skin Inflammation
- (2020) Cristian Scheau et al. MOLECULES
- Pesticides, cognitive functions and dementia: A review
- (2020) Athina-Maria Aloizou et al. TOXICOLOGY LETTERS
- Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases
- (2020) Bahare Salehi et al. Journal of Clinical Medicine
- Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
- (2020) Mehdi Sharifi-Rad et al. Journal of Clinical Medicine
- Behavioral impacts of a mixture of six pesticides on rats
- (2020) Alexander A. Sergievich et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Cannabinoid Ligands Targeting TRP Channels
- (2019) Chanté Muller et al. Frontiers in Molecular Neuroscience
- A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis
- (2019) Gabriella Contarini et al. Journal of Neuroinflammation
- Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis
- (2019) Ting Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
- (2019) Zinah Zamil Al-Ghezi et al. Frontiers in Immunology
- A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse
- (2019) Tsatsakis et al. Journal of Clinical Medicine
- Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE)
- (2019) Vahid Reza Askari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization
- (2018) Molly Braun et al. BRAIN BEHAVIOR AND IMMUNITY
- A cannabinoid receptor 2 agonist reduces blood–brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats
- (2018) Lin Li et al. BRAIN RESEARCH
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Progress and Challenges in Frontotemporal Dementia Research: A 20-Year Review
- (2018) John R. Hodges et al. JOURNAL OF ALZHEIMERS DISEASE
- The Progression of Neuropsychiatric Symptoms in Alzheimer’s Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study
- (2018) Ilona Hallikainen et al. JOURNAL OF ALZHEIMERS DISEASE
- Co-occurrence of depressive symptoms and executive dysfunction after stroke: associations with brain pathology and prognosis
- (2018) Elles Douven et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Progressive multiple sclerosis, cognitive function, and quality of life
- (2018) Helene Højsgaard Chow et al. Brain and Behavior
- The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease
- (2018) Olga N. Kokiko-Cochran et al. Frontiers in Immunology
- Therapeutic applications of cannabinoids
- (2018) Nancy Maurya et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cannabinoid receptor 2 agonist attenuates blood‑brain barrier damage in a rat model of intracerebral hemorrhage by activating the Rac1 pathway
- (2018) Zhe Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis
- (2018) Andrea Manterola et al. NEUROPHARMACOLOGY
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
- (2018) David M. Elliott et al. Frontiers in Immunology
- The Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury
- (2018) Lital Magid et al. JOURNAL OF NEUROTRAUMA
- Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Giancarlo Logroscino et al. LANCET NEUROLOGY
- Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy
- (2017) Jari Nissinen et al. EPILEPSY RESEARCH
- Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis
- (2017) Sabrina Giacoppo et al. FITOTERAPIA
- (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
- (2017) Thaís Alberti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis
- (2017) Ying Shi et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination
- (2017) A Feliu et al. JOURNAL OF NEUROSCIENCE
- Severe traumatic brain injury: targeted management in the intensive care unit
- (2017) Nino Stocchetti et al. LANCET NEUROLOGY
- Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
- (2017) Marco Aurélio Mori et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Multiple sclerosis: Pathology, diagnosis and treatments
- (2017) Wen-Juan Huang et al. Experimental and Therapeutic Medicine
- Recent Advances in Pathophysiology of Traumatic Brain Injury
- (2017) Parmeet Kaur et al. Current Neuropharmacology
- Multiple sclerosis: experimental models and reality
- (2016) Hans Lassmann et al. ACTA NEUROPATHOLOGICA
- An Introduction to the Endogenous Cannabinoid System
- (2016) Hui-Chen Lu et al. BIOLOGICAL PSYCHIATRY
- Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain
- (2016) Margherita Brindisi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis
- (2016) Paula Morales et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epidemiology of Multiple Sclerosis
- (2016) Jonathan Howard et al. NEUROLOGIC CLINICS
- Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
- (2016) A. Vanessa Stempel et al. NEURON
- Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist
- (2016) Wei Bu et al. Frontiers in Neuroscience
- Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants
- (2016) Cristina Miliano et al. Frontiers in Neuroscience
- A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
- (2015) A Feliú et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis
- (2015) Jie Wen et al. NEUROPHARMACOLOGY
- Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
- (2015) A. Rahimi et al. NEUROSCIENCE
- Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
- (2015) Y. Li et al. NEUROSCIENCE
- The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors
- (2015) Miguel Moreno-Martet et al. Multiple Sclerosis and Related Disorders
- A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
- (2015) Sabrina Giacoppo et al. DARU-Journal of Pharmaceutical Sciences
- A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
- (2014) Gloria Hernández-Torres et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189
- (2014) Anton Reiner et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuroinflammation and M2 microglia: the good, the bad, and the inflamed
- (2014) Jonathan D Cherry et al. Journal of Neuroinflammation
- Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats
- (2014) Mutsumi Fujii et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury
- (2014) Flaubert Tchantchou et al. NEUROPHARMACOLOGY
- Freezing of gait in Parkinson's disease: The paradoxical interplay between gait and cognition
- (2014) Lucia Ricciardi et al. PARKINSONISM & RELATED DISORDERS
- A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
- (2014) Francisco J. Carrillo-Salinas et al. PLoS One
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice
- (2013) A. B. Lopez-Rodriguez et al. CEREBRAL CORTEX
- N-arachidonoyl-L-serine (AraS) Possesses Proneurogenic Properties in Vitro and in Vivo after Traumatic Brain Injury
- (2013) Ayelet Cohen-Yeshurun et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Antibody testing for brain immunohistochemistry: Brain immunolabeling for the cannabinoid CB2 receptor
- (2013) Jean-Ha Baek et al. JOURNAL OF NEUROSCIENCE METHODS
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis
- (2013) R. Ribeiro et al. NEUROSCIENCE
- Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
- (2013) Raymond J. M. Niesink et al. Frontiers in Psychiatry
- Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
- (2012) Angelo A Izzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiolic acid prevents vomiting inSuncus murinusand nausea-induced behaviour in rats by enhancing 5-HT1Areceptor activation
- (2012) D Bolognini et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
- (2012) Peter S. Amenta et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Selective Inhibition of Alpha/Beta-Hydrolase Domain 6 Attenuates Neurodegeneration, Alleviates Blood Brain Barrier Breakdown, and Improves Functional Recovery in a Mouse Model of Traumatic Brain Injury
- (2012) Flaubert Tchantchou et al. JOURNAL OF NEUROTRAUMA
- Gait and Cognition: A Complementary Approach to Understanding Brain Function and the Risk of Falling
- (2012) Manuel Montero-Odasso et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects
- (2012) Eva de Lago et al. NEUROPHARMACOLOGY
- Cannabidiol administration after hypoxia–ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
- (2012) M.R. Pazos et al. NEUROPHARMACOLOGY
- Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia
- (2012) W. Schmidt et al. NEUROSCIENCE
- The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors
- (2011) J. R. Savinainen et al. Acta Physiologica
- The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
- (2011) Fernando Correa et al. BRAIN BEHAVIOR AND IMMUNITY
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
- (2011) María S García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotective agents: Cannabinoids
- (2011) A.J. Sánchez et al. CLINICAL IMMUNOLOGY
- Cannabinoid Treatment Renders Neurons Less Vulnerable Than Oligodendrocytes in Experimental Autoimmune Encephalomyelitis
- (2011) Henrik Hasseldam et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Acute Effects of a Selective Cannabinoid-2 Receptor Agonist on Neuroinflammation in a Model of Traumatic Brain Injury
- (2011) Melanie B. Elliott et al. JOURNAL OF NEUROTRAUMA
- Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis
- (2010) Elena Buccellato et al. JOURNAL OF ETHNOPHARMACOLOGY
- Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
- (2010) José L Lanciego et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Environmental factors and their timing in adult-onset multiple sclerosis
- (2010) Adam E. Handel et al. Nature Reviews Neurology
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis
- (2009) D Centonze et al. CELL DEATH AND DIFFERENTIATION
- Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
- (2009) Guy A. Cabral et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
- (2009) M. T. Viscomi et al. JOURNAL OF NEUROSCIENCE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Dual-tasking and gait in people with Mild Cognitive Impairment. The effect of working memory
- (2009) Manuel Montero-Odasso et al. BMC Geriatrics
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide
- (2008) Frida Loría et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules
- (2008) L. Mestre et al. MOLECULAR AND CELLULAR NEUROSCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started